Myocardial Contractility
Myocardial Contractility(心肌收缩力)
Myocardial Contractility 相关产品(33)
- GC40231Milrinone-d3CAS: 2749393-50-6纯度: >99.00%
An internal standard for the quantification of milrinone
- GC41661(±)-4-hydroxy Propranolol β-D-GlucuronideCAS: 94731-13-2纯度: >90.00%
A metabolite of propranolol
- GC424094-hydroxy Nebivolol (hydrochloride)CAS: 2717115-85-8纯度: >98.00%
A major metabolite of nebivolol
- GC44384Neuropeptide Y (3-36) (human, rat) (trifluoroacetate salt)CAS: 150138-78-6纯度: >95.50%
An endogenous C-terminal NPY fragment
- GC44803rac-7-hydroxy Propranolol (hydrochloride)CAS: 76275-67-7纯度: >98.00%
An isomer and metabolite of propranolol
- GC45096Tyr-α-CGRP (human) (trifluoroacetate salt)CAS: 124756-98-5纯度: >95.00%
A tyrosinated analogue of α-CGRP
- GC46304(±)-Nebivolol-d4 (hydrochloride)CAS: 2701283-32-9纯度: >99.00%
A neuropeptide with diverse biological activities
- GC47307Esmolol-d7 (hydrochloride)CAS: 1346598-13-7纯度: >99.00%
An internal standard for the quantification of esmolol
- GC47597Manidipine-d4CAS: 1189656-59-4纯度: >99.00%
An internal standard for the quantification of manidipine
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC18455 | Digoxigenin Monodigitoxoside | 5352-63-6 | - | |
A Na + /K + -ATPase inhibitor | ||||
| GC18474 | Acetyldigitoxin | 1111-39-3 | >95.00% | |
An Na + /K + ATPase inhibitor | ||||
| GC18698 | CAY10665 | 1235543-17-5 | - | |
A stable bioisostere of the antiarrhythmic 17,18-EET | ||||
| GC18716 | Bisindolylmaleimide XI (hydrochloride) | 145333-02-4 | - | |
A PKC inhibitor | ||||
| GC18879 | CAY10662 | 1184844-74-3 | - | |
A urea derivative of 17(18)-EpETE | ||||
| GC40231 | Milrinone-d3 | 2749393-50-6 | >99.00% | |
An internal standard for the quantification of milrinone | ||||
| GC41449 | Carbazeran | 70724-25-3 | >97.00% / >99.00% | |
An inhibitor of PDE2 and PDE3 | ||||
| GC41485 | Digitoxigenin | 143-62-4 | >95.00% | |
A Na + /K + ATPase inhibitor | ||||
| GC41661 | (±)-4-hydroxy Propranolol β-D-Glucuronide | 94731-13-2 | >90.00% | |
A metabolite of propranolol | ||||
| GC42409 | 4-hydroxy Nebivolol (hydrochloride) | 2717115-85-8 | >98.00% | |
A major metabolite of nebivolol | ||||
| GC42548 | 5-hydroxy Saxagliptin (hydrochloride) | - | >95.00% | |
A major active metabolite of saxagliptin | ||||
| GC43062 | C2 Ceramide (d14:1/2:0) | 2097561-20-9 | >98.00% | |
A bioactive sphingolipid | ||||
| GC43565 | Doxorubicinol (hydrochloride) | 63950-05-0 | >90.00% | |
A doxorubicin metabolite | ||||
| GC44013 | KR-32568 | 852146-73-7 | >98.00% | |
An NHE-1 inhibitor | ||||
| GC44358 | Nebivolol O-β-D-Glucuronide | - | >95.00% | |
An active metabolite of nebivolol | ||||
| GC44384 | Neuropeptide Y (3-36) (human, rat) (trifluoroacetate salt) | 150138-78-6 | >95.50% | |
An endogenous C-terminal NPY fragment | ||||
| GC44699 | Propranolol β-D-Glucuronide (sodium salt) | - | >95.00% | |
A major metabolite of propranolol | ||||
| GC44803 | rac-7-hydroxy Propranolol (hydrochloride) | 76275-67-7 | >98.00% | |
An isomer and metabolite of propranolol | ||||
| GC45096 | Tyr-α-CGRP (human) (trifluoroacetate salt) | 124756-98-5 | >95.00% | |
A tyrosinated analogue of α-CGRP | ||||
| GC45728 | Iohexol-d5 | 928623-33-0 | >99.00% | |
An internal standard for the quantification of iohexol | ||||
| GC45903 | Quazinone | 70018-51-8 | >98.00% | |
A PDE3 inhibitor | ||||
| GC46304 | (±)-Nebivolol-d4 (hydrochloride) | 2701283-32-9 | >99.00% | |
A neuropeptide with diverse biological activities | ||||
| GC47307 | Esmolol-d7 (hydrochloride) | 1346598-13-7 | >99.00% | |
An internal standard for the quantification of esmolol | ||||
| GC47597 | Manidipine-d4 | 1189656-59-4 | >99.00% | |
An internal standard for the quantification of manidipine | ||||